Study Details

Back
Study ID 1517-CL-0302
Study Title A Phase 3, Multi-center, Open-label Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia
Clinicaltrials.gov Identifier NCT02780726
Compound Name ASP1517 / roxadustat
Medical Indication or Disease Anemia with chronic kidney disease
Study Sponsor Astellas Pharma Inc.
Collaborator FibroGen
Study Start Date 22-Jun-2016
Study Completion Date 02-Aug-2017
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS